Ibex Wealth Advisors Charles River Laboratories International, Inc. Transaction History

Ibex Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $261,131 - $370,076	-1,022 Closed	0 $0
Q4 2021 Feb 22, 2022	SELL	$351.38 - $448.68 $3.57 Million - $4.56 Million	-10,167 Reduced 90.87%	1,022 $385,000
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $117,754 - $144,822	316 Added 2.91%	11,189 $4.62 Million
Q2 2021 Aug 20, 2021	BUY	$294.17 - $371.65 $143,260 - $180,993	487 Added 4.69%	10,873 $4.02 Million
Q1 2021 May 05, 2021	BUY	$249.67 - $299.48 $2.59 Million - $3.11 Million	10,386 New	10,386 $3.01 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Ibex Wealth Advisors with notifications on news.